
Our business is built on the conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way.
Our key contribution is to discover and develop innovative medicines and make them accessible to patients throughout the world. But we know that to support better diabetes health for generations to come, we must also invest in efforts to prevent type 2 diabetes and obesity, educating healthcare professionals, offering patient support programmes, and ensuring that we have no negative impact on people, communities and the environment.
Manmade climate change and the non-sustainable consumption and disposal of resources are affecting national economies and worsening human health in many parts of the world. In some cases, the effects of climate change are also adding costs and risks that influence the private sector’s ability to deliver competitive results.
At Novo Nordisk, we believe that reducing our environmental impact is both our corporate responsibility and a way to mitigate long-term risk.